Question raised by the PMDA [Design Issues]

posted by Ben – 2021-03-19 15:47 (211 d 16:08 ago) – Posting: # 22275
Views: 712

Hi Helmut

» Based on the agency’s question, what do they require in such a study?
  • 90% CI within 80.00–125.00% (all subjects) and
    »
  • additionally the PE of the Japanese sub-group within 80.00–125.00%?

This is what came to my mind.

» Problematic in the Japanese population is the (age-dependent) high percentage of achlorohydric subjects. IIRC, already at an age of 20 years it is about 20% and increases to more than 80% at 60 years.

Oh, this is interesting. I was not aware of this phenomenon. Do you have a reference and/or an explanation why this is the case?


Best regards,
Ben.

Complete thread:

Activity
 Admin contact
21,730 posts in 4,544 threads, 1,543 registered users;
online 5 (1 registered, 4 guests [including 3 identified bots]).
Forum time: Sunday 08:55 CEST (Europe/Vienna)

Be very, very careful what you put into that head,
because you will never, ever get it out.    Thomas Wolsey

The Bioequivalence and Bioavailability Forum is hosted by
BEBAC Ing. Helmut Schütz
HTML5